The Department of Justice has introduced a pilot program allowing health‑care entities to voluntarily disclose potential False Claims Act violations that are not already known to regulators. Participants can settle for a repayment multiplier of 1.25‑1.6 times the base amount, receive a coordinated public release with the DOJ and HHS, and avoid a corporate integrity agreement, provided they act before any whistleblower or government investigation surfaces.
Experts caution that the program’s benefit hinges on a company’s ability to detect and investigate its own issues swiftly, as most FCA enforcement still originates from whistleblowers. In fiscal year 2025, relators filed 1,297 lawsuits across sectors, 458 of them in health care, accounting for roughly 80% of the government’s recoveries. The pilot remains closed to matters already on the government’s radar and runs through April 22, 2027.
Source: Corporate Compliance Insights